Ioannis Parodis

Karolinska Institutet

Sweden

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

40%

Epidemiology

40%

Systemic Lupus Erythematosus

100%

Autoimmunity

50%

Autoinflammatory Disease

40%

Covid-19

40%

Vaccine Safety

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles30

Lupus nephritis

Article Link

Year:

2025

New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity–could anti-LIN28A enhance precision in diagnostics?

Article Link

Year:

2025

Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1

Article Link

Year:

2025

Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosus.

Article Link

Year:

2025

Unsupervised machine learning identifies distinct SLE patient endotypes with differential response to belimumab

Article Link

Year:

2025

Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus.

Article Link

Year:

2025

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus.

Article Link

Year:

2025

Belimumab efficacy in mucocutaneous manifestations of systemic lupus erythematosus: a large post hoc analysis of five phase III clinical trials

Article Link

Year:

2025

Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey

Article Link

Year:

2025

Updating the OMERACT Systemic Lupus Erythematosus Core Outcome Set

Article Link

Year:

2025

Response to Comment on “Effect of Belimumab on Preventing De Novo Renal Lupus Flares”

Article Link

Year:

2024

Immune Mechanisms and Biomarkers in Systemic Lupus Erythematosus

Article Link

Year:

2024

Patients with NPSLE experience poorer HRQoL and more fatigue than SLE patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity

Article Link

Year:

2024

Belimumab concentration measurements using a homologous anti-idiotype immunoassay.

Article Link

Year:

2024

Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials.

Article Link

Year:

2024

Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study.

Article Link

Year:

2024

Neuropsychiatric involvement in systemic lupus erythematosus contributes to organ damage beyond the nervous system: a post-hoc analysis of 5 phase III randomized clinical trials

Article Link

Year:

2024

Cardiovascular Risk Evaluation in Psoriatic Arthritis by Aortic Stiffness and the Systemic Coronary Risk Evaluation (SCORE): Results of the Prospective PSOCARD Cohort Study.

Article Link

Year:

2024

OMERACT systemic lupus erythematosus domain survey.

Article Link

Year:

2024

Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD dataset.

Article Link

Year:

2024

Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey.

Article Link

Year:

2023

Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey

Article Link

Year:

2023

Intracardiac Thrombi in Morbus Adamantiades–Behçet in Two Swedish Patients

Article Link

Year:

2023

Systematic literature review informing the EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

Article Link

Year:

2023

COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study

Article Link

Year:

2023

EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

Article Link

Year:

2023

Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials

Article Link

Year:

2023

Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab

Article Link

Year:

2023

Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State

Article Link

Year:

2023

COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis.

Article Link

Year:

2022

Collaborators16

Pier Paolo Sainaghi

Professore Associato in Medicina Interna

Università degli Studi del Piemonte Orientale

ITALY

John D. Pauling

UNITED KINGDOM

Silvia Aguilera

EPFL (École Polytechnique Fédérale de Lausanne)

SWITZERLAND

Anthony Redmond

Professor of Clinical Biomechanics

University of Leeds

UNITED KINGDOM

Nilesh Srivastav

Lecturer

Melbourne Institute, University of Melbourne

AUSTRALIA

João Eurico Fonseca

PORTUGAL

Tanja Stamm

Medical University of Vienna

AUSTRIA

Hans-Joachim Anders

GERMANY

Brad H Rovin

The Ohio State University Wexner Medical Center

UNITED STATES

Laura ANDREOLI

University of Brescia

ITALY

Denis Lagutkin

Karolinska Institutet

SWEDEN

Andreas Schwarting

Head, Division of Rheumatology and Clinical Immunology, Prof.Dr.

University Medical Center of the Johannes Gutenberg University Mainz

GERMANY

Elisabet Welin

professor

Örebro university

SWEDEN

Alvaro Gomez

Karolinska Institutet

SWEDEN

Yvonne Enman

Karolinska Institutet

SWEDEN

Christopher Sjöwall

Senior Associate Professor

Linköping University

SWEDEN

How do I reach out?

Meet Kite AI